0.91 USD
▲+0.01+9.50%
盘后 0.82 -0.97%
2026-08-03
市值
$10.35M
市盈率
—
EPS
-0.95
股息率
—
52 周区间
0.75 – 2.29
成交量
782.01K
Beta
0.51
目标价
15.50
52W 低 0.7552W 高 2.29
价格走势
公司简介
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. The company’s lead product candidate is CardiAMP, an autologous mononuclear cell therapy system in Phase III clinical trial for the treatment of ischemic heart failure with reduced ejection fraction and refractory angina resulting from chronic myocardial ischemia. It also provides CardiALLO, an allogeneic mesenchymal stem cell therapy which is in phase II for ischemic he...